Skip to main content
Log in

Caspofungin treatment of Pneumocystis pneumonia during conditioning for bone marrow transplantation

  • Brief Report
  • Published:
European Journal of Clinical Microbiology and Infectious Diseases Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Marras TK, Sanders K, Lipton JH et al (2002) Aerosolized pentamidine prophylaxis for Pneumocystis carinii pneumonia after allogeneic marrow transplantation. Transpl Infect Dis 1:66–74

    Article  Google Scholar 

  2. Ma L, Kovacs JA, Cargnel A et al (2002) Mutations in the dihydropteroate synthase gene of human-derived Pneumocystis carinii isolates from Italy are infrequent but correlate with prior sulfa prophylaxis. J Infect Dis 185:1530–1532

    Article  PubMed  CAS  Google Scholar 

  3. Kazanjian P, Armstrong W, Hossler PA et al (2000) Pneumocystis carinii mutations are associated with duration of sulfa or sulfone prophylaxis exposure in AIDS patients. J Infect Dis 182:551–557

    Article  PubMed  CAS  Google Scholar 

  4. Navin TR, Beard CB, Huang L et al (2001) Effect of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of P carinii pneumonia in patients with HIV-1: a prospective study. Lancet 358:545–549

    Article  PubMed  CAS  Google Scholar 

  5. Van de Poll ME, Relling MV, Schuetz EG et al (2001) The effect of atovaquone on etoposide pharmacokinetics in children with acute lymphoblastic leukemia. Cancer Chemother Pharmacol 47:467–472

    Article  PubMed  Google Scholar 

  6. Crothers K, Beard CB, Turner J et al (2005) Severity and outcome of HIV-associated Pneumocystis pneumonia containing Pneumocystis jirovecii dihydropteroate synthase gene mutations. AIDS 19:801–805

    Article  PubMed  Google Scholar 

  7. Pareja JP, Garland R, Koziel H (1998) Use of adjunctive corticosteroids in severe adult non-HIV Pneumocystis carinii pneumonia. Chest 113:1215–1224

    Article  PubMed  CAS  Google Scholar 

  8. Colby C, McAfee S, Sackstein R et al (1999) A prospective randomized trial comparing the toxicity and safety of atovaquone with trimethoprim/sulfamethoxazole as Pneumocystis carinii pneumonia prophylaxis following autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 24:897–902

    Article  PubMed  CAS  Google Scholar 

  9. Deresinski SC, Stevens DA (2003) Caspofungin. Clin Infect Dis 36:1445–1457

    Article  PubMed  CAS  Google Scholar 

  10. Letscher-Bru V, Herbrecht R (2003) Caspofungin: the first representative of a new antifungal class. J Antimicrob Chemother 51:513–521

    Article  PubMed  CAS  Google Scholar 

  11. Powles MA, Liberator P, Anderson J et al (1998) Efficacy of MK-991 (L-743,872), a semisynthetic pneumocandin, in murine models of Pneumocystis carinii. Antimicrob Agents Chemother 4:1985–1989

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to C. Annaloro.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Annaloro, C., Della Volpe, A., Usardi, P. et al. Caspofungin treatment of Pneumocystis pneumonia during conditioning for bone marrow transplantation. Eur J Clin Microbiol Infect Dis 25, 52–54 (2006). https://doi.org/10.1007/s10096-005-0065-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10096-005-0065-z

Keywords

Navigation